Insulet (PODD) Accumulated Depreciation & Amortization (2010 - 2025)

Insulet (PODD) reported Accumulated Depreciation & Amortization of $432.8 million for Q4 2025, up 19.43% on a YoY basis from $362.4 million in Q4 2024, and up 19.43% quarter-over-quarter from $362.4 million in Q4 2024.

Insulet (PODD) Accumulated Depreciation & Amortization (2010 - 2025) Analysis & Trends

Insulet has reported Accumulated Depreciation & Amortization for 16 years, with the latest figure at $432.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 19.43% year-over-year to $432.8 million; the trailing twelve-month figure through Dec 2025 stood at $432.8 million (up 19.43% YoY), and the FY2025 full-year result was $432.8 million, up 19.43% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 stood at $432.8 million, up from $362.4 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $432.8 million in Q4 2025, with the low at $57.4 million in Q4 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $241.8 million across 5 years, with a median of $293.2 million in 2023.
  • Annual changes were most pronounced in 2021 — Accumulated Depreciation & Amortization rose 3.61% — and 2023, when it jumped 363.92%.
  • Insulet's Accumulated Depreciation & Amortization stood at $57.4 million in 2021, then increased by 10.1% to $63.2 million in 2022, then jumped by 363.92% to $293.2 million in 2023, then gained by 23.6% to $362.4 million in 2024, then advanced by 19.43% to $432.8 million in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at $432.8 million (Q4 2025), $362.4 million (Q4 2024), and $293.2 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Insulet 10.47 Bn 9.99 Bn 529.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 432.80 Mn
Dec 31, 2025 432.80 Mn
Dec 31, 2024 362.40 Mn
Dec 31, 2024 362.40 Mn
Dec 31, 2023 293.20 Mn
Dec 31, 2023 293.20 Mn
Dec 31, 2022 63.20 Mn
Dec 31, 2022 63.20 Mn
Dec 31, 2021 57.40 Mn
Dec 31, 2021 57.40 Mn
Dec 31, 2020 55.40 Mn
Dec 31, 2020 55.40 Mn
Dec 31, 2019 27.90 Mn
Dec 31, 2019 27.90 Mn
Dec 31, 2018 15.60 Mn
Dec 31, 2018 15.60 Mn
Dec 31, 2017 13.90 Mn
Dec 31, 2017 13.90 Mn
Dec 31, 2016 13.83 Mn
Dec 31, 2016 13.83 Mn